Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2012
12/05/2012EP2528586A1 Effervescent formulations comprising cefixime and clavulanic acid as active agents
12/05/2012EP2528585A1 Pharmaceutical compositions comprising tiotropium, formoterol and budesonide
12/05/2012EP2528584A1 Water dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections
12/05/2012CN1893977B Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient.
12/05/2012CN102811739A T Cell Activation Inhibitor, Pharmaceutical Composition Containing Same, And Screening Method For T Cell Activation Inhibiting Substance
12/05/2012CN102811728A Boswellia oil, its fractions and compositions for enhancing brain function
12/05/2012CN102805868A Method of treatment using ligand-immunogen conjugates
12/05/2012CN102805867A Application of transcription factor NFATC3 as drug target in reversing multidrug resistance of tumor
12/05/2012CN102805866A Pharmaceutic preparation for livestock and application thereof
12/05/2012CN102302784B Tumor chemotherapeutic medicinal preparation and preparation method thereof
12/05/2012CN102120031B Pharmaceutical compositions and methods for accelerating wound healing
12/05/2012CN102106851B Application of brusatol as chemotherapeutic drug synergist
12/05/2012CN101784285B Composition for ophthalmic disease associated with hypoxia or ischemia
12/05/2012CN101610790B Novel compositions and uses thereof
12/05/2012CN101590229B Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
12/05/2012CN101590084B Pharmaceutical composition containing angiotensin converting enzyme inhibitors, B vitamins and ginkgo biloba extracts
12/05/2012CN101415424B Combinations comprising BCR-ABL/C-KIT/PDGF-R TK inhibitors for treating cancer
12/05/2012CN101415409B Combinations of therapeutic agents for treating cancer
12/05/2012CN101277740B Antituberculous composition comprising oxazole compounds
12/04/2012US8324283 Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
12/04/2012US8324282 Alkylating agent combinations in the treatment of cancer
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012US8323668 Prevention and treatment of gram negative, flagellated bacterial infections
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012US8323635 Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
12/04/2012US8323634 Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor
12/04/2012CA2678135C Method for increasing hair growth using a creatine compound
12/04/2012CA2611722C A model animal for white hair development with mutations in the ret and ednrb genes
12/04/2012CA2582934C Composition containing omega-3 fatty acids and omega-6 fatty acids
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2557269C Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
12/04/2012CA2538078C Rifalazil formulations
12/04/2012CA2537748C Use of telmisartan for the prevention of vascular headache
12/04/2012CA2495570C Immunostimulatory compositions and methods of stimulating an immune response
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2428834C Biodegradable poly(beta-amino esters) and uses thereof
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2400868C Anti-egfrviii scfvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
12/04/2012CA2222509C Connective tissue growth factor
12/04/2012CA2210484C Composition to ameliorate osteolysis and metastasis
11/2012
11/29/2012WO2012162372A1 Combination therapy of hsp90 inhibitory compounds with mtor/p13k inhibitors
11/29/2012WO2012162293A1 Combination therapy of hsp90 inhibitory compounds with mek inhibitors
11/29/2012WO2012162210A1 Ring constrained cationic lipids for oligonucleotide delivery
11/29/2012WO2012161301A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012WO2012161196A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
11/29/2012US20120302649 Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
11/29/2012US20120302532 Combinations comprising antimuscarinic agents and corticosteroids
11/29/2012US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301426 Alkanoylamino benzamide aniline hdac inhibitor compounds
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012CA2840336A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/28/2012EP2527008A2 Anticancerous polymeric agents
11/28/2012EP2526953A1 Methods and pharmaceutical compositions for healing wounds
11/28/2012EP2526952A1 Methods and pharmaceutical compositions for healing wounds
11/28/2012EP2526946A1 Methods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione For Treatment Of Certain Leukemias
11/28/2012EP2526943A1 Liquid formulation comprising an alpha-2 receptor agonist (e.g. clonidin) and oxybutynin (anti-muscarinic agent) for the treatment of sialorrhoea
11/28/2012EP2526938A2 Histidine decarboxylase inhibitor sole or combined with a leukotriene receptor antagonist, an anti-H1 and/or an anti-H2 to treat COPD or gastrointestinal disorders.
11/28/2012EP2526937A1 Composition for prevention of recurrence of stroke
11/28/2012EP2525825A1 Combination therapy to treat autoimmune diseases
11/28/2012EP2525797A1 Methods for treating pain
11/28/2012EP2525789A1 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
11/28/2012CN1895671B Compound preparation for treating viral liver disease
11/28/2012CN102803239A Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
11/28/2012CN102802625A Therapeutic combinations of theobromine and an antihistamine
11/28/2012CN102802620A Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
11/28/2012CN102802438A Method for reducing unpleasant taste
11/28/2012CN102793929A Method for preparing stable amorphous drug preparation
11/28/2012CN102793921A Methods for treating tweak-related conditions
11/28/2012CN102793696A Application of butylphthalide in preparation of medicament for treating bronchial asthma
11/28/2012CN102247315B OTC (Over the Counter) drug frozen sucker for treating symptoms of upper respiratory tract and oral cavity and preparation method thereof
11/28/2012CN101917990B Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
11/28/2012CN101862456B Remedy
11/28/2012CN101850119B Compound preparation used for treating melancholia and senile dementia
11/28/2012CN101703777B Tamper-resistant oral opioid agonist formulations
11/28/2012CN101636180B Peptide compounds for treating refractory status epilepticus
11/28/2012CN101331134B Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/28/2012CN101199850B Skin compound agent of oxide stress window period interference method
11/27/2012US8318952 Substituted indole derivatives for the treatment of respiratory diseases
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318813 Method of treating binge eating disorder
11/27/2012US8318810 Methods for treating neural cell swelling
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318721 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/27/2012US8318669 Method of regulating glucose metabolism, and reagents related thereto
11/27/2012US8318666 Use of leptin to treat metabolic abnormalities associated with lipoatrophy
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012US8318213 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/27/2012US8318188 Medium chain peroxycarboxylic acid compositions
11/27/2012US8318179 Neisserial vaccines
11/27/2012US8318177 Viral chemokine-antigen fusion proteins
11/27/2012US8318147 Use of IL-29 for treating a dengue virus infection
11/27/2012CA2615975C Compositions for reducing the incidence of drug induced arrhythmia
11/27/2012CA2481390C Nanoparticulate megestrol formulations
11/27/2012CA2414247C Cosmetic composition and method comprising a hydroxamate mmpi and a triterpenoid glycoside
11/27/2012CA2359360C In vitro screening method for identifying selective binding partners for 5-ht5-receptors
11/27/2012CA2333755C The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
11/22/2012WO2012157751A1 Diagnosis of respiratory tract infectious diseases using urine specimens
11/22/2012WO2012157750A1 Diagnosis of respiratory tract infectious disease using blood specimens
11/22/2012WO2012157737A1 Immunity inducing agent
1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 1151